Achilles Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 65.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
27%	Syncona Investment Management Limited	11,086,909	US$11.9m	0%	11.35%
9.98%	BML Capital Management, LLC	4,100,002	US$4.4m	556%	2.1%
5.82%	Forbion Capital Partners B.V.	2,390,050	US$2.6m	0%	0.41%
3.91%	Redmile Group, LLC	1,608,089	US$1.7m	0%	0.09%
3.65%	Vestal Point Capital, LP	1,500,000	US$1.6m	0%	0.13%
3.51%	Ikarian Capital, LLC	1,443,181	US$1.5m	0%	0.43%
2.71%	Iraj Ali	1,112,325	US$1.2m	0%	no data
1.84%	Artal Group S.A.	755,375	US$809.4k	0%	0.02%
1.55%	Renaissance Technologies LLC	638,133	US$683.8k	-6.53%	no data
1.36%	Karl Peggs	560,137	US$600.2k	0%	no data
1.12%	Sergio Quezada	461,835	US$494.9k	0%	no data
1.02%	Boothbay Fund Management, LLC	420,481	US$450.5k	0%	0.01%
0.66%	Robert Coutts	269,600	US$288.9k	0%	no data
0.61%	Acadian Asset Management LLC	250,825	US$268.8k	0%	no data
0.55%	Edwin Moses	226,250	US$242.4k	0%	no data
0.11%	Michael Giordano	46,663	US$50.0k	0%	no data
0.054%	Two Sigma Advisers, LP	22,400	US$24.0k	-4.68%	no data
0.053%	Geode Capital Management, LLC	21,590	US$23.1k	0%	no data
0.052%	Two Sigma Investments, LP	21,249	US$22.8k	-1.07%	no data
0.049%	Corsair Capital Management, L.P.	20,000	US$21.4k	0%	no data
0.044%	Bg Fund Management Luxembourg S.A.	17,900	US$19.2k	0%	no data
0.04%	Morgan Stanley, Investment Banking and Brokerage Investments	16,431	US$17.6k	84%	no data
0.035%	Baader Bank AG, Asset Management Arm	14,184	US$15.2k	14.7%	no data
0.03%	Susquehanna International Group, LLP, Asset Management Arm	12,434	US$13.3k	0%	no data
0.024%	Brave Asset Management, Inc.	10,000	US$10.7k	0%	no data